Aptose Biosciences Investor Relations Material
Latest events
EGM 2024
Aptose Biosciences
Q1 2025
8 May, 2025
Q4 2024
27 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Aptose Biosciences Inc
Access all reports
Aptose Biosciences Inc. is a clinical-stage biotechnology company focused on developing targeted therapies for hematologic malignancies, including leukemia, lymphoma, and myeloma. The company leverages innovative approaches in small-molecule drug design to address unmet medical needs in cancer treatment. The company is headquartered in Toronto, Canada, and its shares are listed on the NASDAQ.
Latest articles
)
Luca de Meo: Succeeding Pinault as the New CEO of Kering
Luca de Meo's leap from auto to luxury marks a bold new chapter as he becomes the first non-Pinault CEO to lead the Kering empire.
16 Jun 2025
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
Ticker symbol
APTO
Country
🇺🇸 United States